tiprankstipranks
Rising High: Exclusive talk with pharmaceutical development company MIRA
PremiumThe FlyRising High: Exclusive talk with pharmaceutical development company MIRA
1M ago
COMPASS Pathways Boosts Funds for Mental Health Trials
Premium
Company Announcements
COMPASS Pathways Boosts Funds for Mental Health Trials
1M ago
Compass Pathways 24M ADS Secondary priced at $5.796
Premium
The Fly
Compass Pathways 24M ADS Secondary priced at $5.796
1M ago
Rising High: Cannabis firms report quarterly earnings
PremiumThe FlyRising High: Cannabis firms report quarterly earnings
2M ago
Rising High: Numinus Wellness to sell five Utah clinics for $3.53M
Premium
The Fly
Rising High: Numinus Wellness to sell five Utah clinics for $3.53M
3M ago
Atai Life Sciences price target lowered to $10 from $15 at H.C. Wainwright
Premium
The Fly
Atai Life Sciences price target lowered to $10 from $15 at H.C. Wainwright
3M ago
Compass Pathways price target lowered to $18 from $23 at RBC Capital
PremiumThe FlyCompass Pathways price target lowered to $18 from $23 at RBC Capital
4M ago
Compass Pathways price target lowered to $12 from $22 at Maxim
Premium
The Fly
Compass Pathways price target lowered to $12 from $22 at Maxim
4M ago
Compass Pathways Focuses on Key Psilocybin Program
Premium
Company Announcements
Compass Pathways Focuses on Key Psilocybin Program
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100